KRAS G13D mutation and sensitivity to cetuximab or panitumumab in a colorectal cancer cell line model

Simple item page
dc.contributor.authorSree Kumar, S.
dc.contributor.authorPrice, T.
dc.contributor.authorMohyieldin, O.
dc.contributor.authorBorg, M.
dc.contributor.authorTownsend, A.
dc.contributor.authorHardingham, J.
dc.date.issued2014
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityShalini Sree Kumar, Timothy J. Price, Omar Mohyieldin, Matthew Borg, Amanda Townsend and Jennifer E. Hardingham
dc.identifier.citationGastrointestinal cancer research : GCR, 2014; 7(1):23-26
dc.identifier.issn1934-7820
dc.identifier.issn1934-7987
dc.identifier.orcidPrice, T. [0000-0002-3922-2693]
dc.identifier.orcidBorg, M. [0000-0003-4741-553X]
dc.identifier.orcidTownsend, A. [0000-0003-3563-4719]
dc.identifier.orcidHardingham, J. [0000-0001-8277-1199]
dc.identifier.urihttp://hdl.handle.net/2440/91197
dc.language.isoen
dc.publisherInternational Society of Gastrointestinal Oncology
dc.rights© 2014 by International Society of Gastrointestinal Oncology
dc.source.urihttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930148/
dc.titleKRAS G13D mutation and sensitivity to cetuximab or panitumumab in a colorectal cancer cell line model
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medical Sciences publications